February 3, 2023
Roche and Chugai Pharmaceutical have removed their Alzheimer’s drug candidate gantenerumab from the pipeline following clinical trial failures last year, according to their update on February 2. In November, the Swiss pharma giant had reported that the drug failed to...read more